Paradoximmuno
Founded 2019 · 11 employees on LinkedIn · 3 known investors
Find your way into Paradoximmuno
Sign up to see every warm intro you have to Paradoximmuno
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Paradoximmuno team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Paradox Immuno develops a platform for discovering therapies targeting protein misfolding diseases, leveraging proprietary research and lead identification technology to address rare conditions with no existing treatments.
Founders & leadership
Paradoximmuno was founded in 2019 by Yulong Sun, PhD.
Investors · 3
Ontario Centre of Innovationlisted by Ontario Centre of InnovationToronto · $500K
How we know: Ontario Centre of Innovation's portfolio page · Not right? Tell us
Frequently asked questions
- What does Paradoximmuno do?
- Paradox Immuno develops a platform for discovering therapies targeting protein misfolding diseases, leveraging proprietary research and lead identification technology to address rare conditions with no existing treatments.
- Who founded Paradoximmuno?
- Paradoximmuno was founded by Yulong Sun, PhD in 2019.
- Who are Paradoximmuno's investors?
- Paradoximmuno's investors include Beresford Ventures, Ontario Centre of Innovation, Ontario Centre of Innovation programs.



